Zentalis Pharmaceuticals (ZNTL) Operating Leases (2020 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Operating Leases of $38.7 million for Q1 2026, down 8.32% year-over-year from $42.2 million in Q1 2025, and up 8.25% quarter-over-quarter from $35.7 million in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Operating Leases (2020 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Operating Leases history runs 7 years deep, the most recent figure standing at $38.7 million for Q1 2026.
- In Q1 2026, Operating Leases fell 8.32% year-over-year to $38.7 million; the TTM figure through Mar 2026 stood at $38.7 million (down 8.32% YoY), while the FY2025 annual figure was $35.7 million, down 9.79% from the prior year.
- Operating Leases for Q1 2026 stood at $38.7 million, up from $35.7 million in the prior quarter.
- The five-year high for Operating Leases was $47.0 million in Q1 2023, with the low at $35.7 million in Q4 2025.
- The 5-year median for Operating Leases is $42.7 million (2023), against an average of $41.9 million.
- The sharpest annual moves came in 2022 and 2025: Operating Leases rose 1.59% in 2022, then slipped 9.79% in 2025.
- Zentalis Pharmaceuticals' Operating Leases stood at $45.2 million in 2022, then declined by 4.46% to $43.2 million in 2023, then retreated by 8.28% to $39.6 million in 2024, then declined by 9.79% to $35.7 million in 2025, then rose by 8.25% to $38.7 million in 2026.
- Business Quant data shows ZNTL's Operating Leases at $38.7 million in Q1 2026, $35.7 million in Q4 2025, and $36.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.69 Mn |
| Mar 31, 2026 | 38.65 Mn |
| Dec 31, 2025 | 35.70 Mn |
| Sep 30, 2025 | 36.71 Mn |
| Jun 30, 2025 | 41.32 Mn |
| Mar 31, 2025 | 42.16 Mn |
| Dec 31, 2024 | 39.58 Mn |
| Sep 30, 2024 | 40.46 Mn |
| Jun 30, 2024 | 44.03 Mn |
| Mar 31, 2024 | 45.36 Mn |
| Dec 31, 2023 | 43.15 Mn |
| Sep 30, 2023 | 43.27 Mn |
| Jun 30, 2023 | 44.03 Mn |
| Mar 31, 2023 | 47.02 Mn |
| Dec 31, 2022 | 45.17 Mn |
| Dec 31, 2021 | 44.46 Mn |
| Dec 31, 2020 | 1.10 Mn |